Validea Detailed Fundamental Analysis

Validea's guru fundamental report for Danaher Corp (DHR) assigned a 55% rating when evaluated against its Small-Cap Growth Investor model, based on the Motley Fool strategy. Despite DHR being a large-cap growth stock, this score falls significantly below the 80% threshold for 'some interest,' indicating it fails on several key growth and valuation metrics including relative strength, sales and EPS growth, profit margin consistency, and the 'Fool Ratio' (P/E to growth).

Analysis

Danaher Corp (DHR) scores a notably low 55% on Validea's Small-Cap Growth Investor model, which is based on the Motley Fool strategy, falling well short of the 80% threshold that indicates strategic interest. This weak score is particularly significant as it stems from failures in several critical growth and momentum criteria. Specifically, DHR fails on relative strength, year-over-year sales and EPS growth comparisons, profit margin consistency, and the P/E-to-growth or "Fool Ratio". These shortcomings suggest that, according to this model, the company currently lacks the price momentum and accelerating growth profile sought by growth-oriented investors. Further flags are raised by a high long-term debt-to-equity ratio and failures on metrics like sales volume and average shares outstanding. Despite these significant weaknesses, the analysis does highlight fundamental strengths, including a passing grade on its current profit margin, strong insider holdings, positive cash flow from operations, and effective management of working capital as seen in the inventory-to-sales and accounts receivable-to-sales ratios. The passing grade on R&D spending is also a positive for a firm in the Scientific & Technical Instruments industry. The overall picture is of a company with some solid operational fundamentals but one that is not currently exhibiting the dynamic growth characteristics required to pass a stringent growth-focused screen.

Key Decisions for Investors

• Investors with a growth-oriented mandate should exercise caution, as DHR's failure on key metrics like relative strength, sales growth, and the P/E-to-growth ratio indicates a misalignment with typical growth stock criteria.
• Monitor the specific failed metrics, particularly sales and EPS growth deceleration and profit margin consistency, as any positive reversal in these areas could signal a fundamental shift in the company's trajectory.
• The high long-term debt-to-equity ratio identified by a failed test warrants closer scrutiny as a key financial risk factor, especially in the context of the current macroeconomic environment.
• For investors with a quality or value focus, the company's strengths in cash flow generation, R&D investment, and insider holdings might still present a case for consideration, provided the lack of growth momentum is acceptable within their strategy.